Exterior of the Domus Vi Alcoy residence. | ARCHIVE
The trial for the deaths that occurred in Domus Vi Alcoy between March and April 2020 has continued today in the sixth hearing, which was attended by more experts from the defendant, in this case, from Quavitae.
This is the case of two internists, one from Barcelona and the other from Madrid, in whose interventions, have pointed to the previous pathologies of the deceased users and also their age as the main reason for the cause of deaths, although Covid-19 could accelerate or even aggravate the disease processsuch as dementia or neurodegenerative diseases. They have pointed out that they were terminally ill, arguing that this situation means if the disease they suffer from has no cure or treatment and if it presents various symptoms, in addition to considering that the imminent death of said people would not be surprising due to their condition.
In this way, experts have stated that Covid-19 was not the cause of death of any of the deceased residents whose relatives are part of the lawsuit: «in the death certificates of the 18, there are written in different sections, not in the corresponding one, possible coronavirus infection, suspicion of coronavirus infection, but this is not a definition of coronavirus disease ».
However, as the lawyer for the relatives who have filed the lawsuit has pointed out, There were cases of users who had been suffering from dementia for many years and yet, the death occurred in the first weeks of the pandemic.
Regarding age, they have indicated that the deceased persons referred to in the lawsuit had a average age of 86 years, exceeding the 83-84 year life expectancy in Spain.
In their reports they rule out malpractice on the part of Domus Vi Alcoy, It has even been stated that “the residence could not do more than what it did”describing the “handling of each of them as “impeccable.” This contrasts with the statements of the experts provided by the plaintiff.
Finally, a expert opinion also provided by the defendant has reduced the valuation of the compensation –in case the judge so considers–, alleging mainly that none of the plaintiffs lived with the deceased, but also other issues such as the consequences.
Related news:
Covid-19 Debate Intensifies: New Insights Emerge in Domus Vi Alcoy Trial
The ongoing trial surrounding the deaths at the Domus Vi Alcoy residence between March and April 2020 has taken a significant turn, as experts testified in the sixth hearing, shedding light on the mysterious circumstances surrounding these unfortunate events. The question on everyone’s mind has been whether Covid-19 was the primary cause of these deaths. However, the latest testimonies from two internists from Quavitae have challenged this narrative, introducing a more nuanced understanding of the situation.
According to the experts, the primary factors contributing to the deaths of the Domus Vi Alcoy residents were their pre-existing pathologies and advanced age. While Covid-19 may have accelerated or aggravated these conditions, it was not solely responsible for the fatalities. This testimony provides a valuable counterpoint to the widely-held assumption that Covid-19 was the primary cause of these deaths.
The introduction of this new perspective raises essential questions about our understanding of the pandemic and how we respond to such crises. If age and pre-existing conditions played a more significant role in these deaths than initially thought, it challenges our assumptions about who is most vulnerable to infection and how we prioritize our medical resources.
Furthermore, this testimony suggests that the narrative surrounding these deaths has been oversimplified. The reality is that many patients, particularly the elderly and those with underlying conditions, are often fighting multiple health battles simultaneously. In this context, Covid-19 may be an exacerbating factor, but it is not the sole contributor to these tragic outcomes.
As the trial continues, it will be essential to carefully weigh these new findings and consider the implications for our understanding of the pandemic. This new information should prompt us to reevaluate our responses to such crises, acknowledging the complex interplay between various health factors and the need for comprehensive and nuanced care.
the Domus Vi Alcoy trial has unearthed more questions than answers, but this latest development provides a critical reminder of the importance of careful analysis and nuanced understanding in addressing complex health crises.
